Page 52 - Haematologica-April 2018

T. Lefebvre et al.
logical implications. Blood Rev. 2016;
30(6):431-437
6. Franco M, Collec E, Connes P, et al.
Abnormal properties of red blood cells sug- gest a role in the pathophysiology of Gaucher disease. Blood. 2013; 121(3):546- 555.
7. Reihani N, Arlet J-B, Dussiot M, et al. Unexpected macrophage-independent dyserythropoiesis in Gaucher disease. Haematologica. 2016;101(12):1489-1498.
8. Barton NW, Brady RO, Dambrosia JM, et al. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher’s disease. N Engl J Med. 1991;324(21):1464-1470.
9. Mekinian A, Stirnemann J, Belmatoug N, et al. Ferritinemia during type 1 Gaucher dis- ease: mechanisms and progression under treatment. Blood Cells Mol Dis. 2012;49(1):53-57.
10. Medrano-Engay B, Irun P, Gervas-Arruga J, et al. Iron homeostasis and infIammatory biomarker analysis in patients with type 1 Gaucher disease. Blood Cells Mol Dis. 2014;53(4):171-175.
11. Lorenz F, Pawłowicz E, Klimkowska M, et al. Ferritinemia and serum inflammatory cytokines in Swedish adults with Gaucher disease type 1. Blood Cells Mol Dis. 2018;68:35-42.
12. Finch CA, Bellotti V, Stray S, et al. Plasma ferritin determination as a diagnostic tool. West J Med. 1986;145(5):657-663.
13. Nicolas G, Bennoun M, Devaux I, et al. Lack of hepcidin gene expression and severe tis- sue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA. 2001; 98(15):8780-8785.
14. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicro- bial peptide hepcidin, is overexpressed dur- ing iron overload. J Biol Chem. 2001; 276(11):7811-7819.
15. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004; 306(5704): 2090-2093.
16. Delaby C, Pilard N, Gonçalves AS, Beaumont C, Canonne-Hergaux F. Presence of the iron exporter ferroportin at the plas- ma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin. Blood. 2005;106(12):3979-3984.
17. Brasse-Lagnel C, Karim Z, Letteron P, et al. Intestinal DMT1 cotransporter is down- regulated by hepcidin via proteasome inter- nalization and degradation. Gastroenterology. 2011;140(4):1261-1271.
18. Mena NP, Esparza A, Tapia V, Valdés P, Núñez MT. Hepcidin inhibits apical iron uptake in intestinal cells. Am J Physiol Gastrointest Liver Physiol. 2008; 294(1):G192-198.
19. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulato- ry hormone hepcidin. J Clin Invest. 2004; 113(9):1271-1276.
20. Weiss G, Goodnough LT. Anemia of chron- ic disease. N Engl J Med. 2005; 352(10):1011-1023.
21. Kulaksiz H, Theilig F, Bachmann S, et al. The iron-regulatory peptide hormone hep- cidin: expression and cellular localization in the mammalian kidney. J Endocrinol. 2005;184(2):361–370.
22. Moulouel B, Houamel D, Delaby C, et al. Hepcidin regulates intrarenal iron handling at the distal nephron. Kidney Int. 2013; 84(4):756-766.
23. Gnana-Prakasam JP, Martin PM, Mysona BA, et al. Hepcidin expression in mouse reti- na and its regulation via lipopolysaccha- ride/Toll-like receptor-4 pathway independ- ent of Hfe. Biochem J. 2008; 411(1):79-88.
24. Schwarz P, Kübler JAM, Strnad P, et al. Hepcidin is localised in gastric parietal cells, regulates acid secretion and is induced by Helicobacter pylori infection. Gut. 2012; 61(2):193-201.
25. Kulaksiz H, Fein E, Redecker P, et al. Pancreatic beta-cells express hepcidin, an iron-uptake regulatory peptide. J Endocrinol. 2008;197(2):241-249.
26. Merle U, Fein E, Gehrke SG, Stremmel W, Kulaksiz H. The iron regulatory peptide hepcidin is expressed in the heart and regu- lated by hypoxia and inflammation. Endocrinology. 2007;148(6):2663-2668.
27. Frazier MD, Mamo LB, Ghio AJ, Turi JL. Hepcidin expression in human airway epithelial cells is regulated by interferon-g. Respir Res. 2011;12:100.
28. Bekri S, Gual P, Anty R, et al. Increased Adipose Tissue Expression of Hepcidin in Severe Obesity Is Independent From Diabetes and NASH. Gastroenterology. 2006;131(3):788-796.
29. Peyssonnaux C, Zinkernagel AS, Datta V, et al. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood. 2006;107(9):3727-3732.
30. Lefebvre T, Dessendier N, Houamel D, et al. LC-MS/MS method for hepcidin-25 measurement in human and mouse serum: clinical and research implications in iron disorders. Clin Chem Lab Med. 2015; 53(10):1557-1567.
31. Domellöf M, Braegger C, Campoy C, et al.
Iron requirements of infants and toddlers. J. Pediatr. Gastroenterol. Nutr. 2014; 58(1):119-129.
32. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002; 110(7):1037-1044.
33. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulato- ry hormone hepcidin. J Clin Invest. 2004; 113(9):1271-1276.
34. Allen MJ, Myer BJ, Khokher AM, Rushton N, Cox TM. Pro-inflammatory cytokines and the pathogenesis of Gaucher’s disease: increased release of interleukin-6 and inter- leukin-10. QJM Mon. J Assoc Physicians. 1997;90(1):19-25.
35. Barak V, Acker M, Nisman B, et al. Cytokines in Gaucher’s disease. Eur Cytokine Netw. 1999;10(2):205-210.
36. Pandey MK, Burrow TA, Rani R, et al. Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease. Nature. 2017; 543(7643):108-112.
37. Boven LA, van Meurs M, Boot RG, et al. Gaucher cells demonstrate a distinct macrophage phenotype and resemble alter- natively activated macrophages. Am J Clin. Pathol. 2004;122(3):359-369.
38. Hunt JR. How important is dietary iron bioavailability? Am J Clin Nutr. 2001; 73(1):3-4.
39. Bogoeva B, Petrusevska G. Immunohistochemical and ultrastructural features of Gaucher’s cells--five case reports. Acta Medica Croat. Cas. Hravatske Akad Med Znan. 2001;55(3):131-134.
40. Lee RE, Balcerzak SP, Westerman MP. Gaucher’s disease. A morphologic study and measurements of iron metabolism. Am J Med. 1967;42(6):891-898.
41. Lorber M. Adult-type Gaucher’s disease: a secondary disorder of iron metabolism. Mt Sinai J Med N Y. 1970;37(4):404-417.
42. Bitton A, Etzell J, Grenert JP, Wang E. Erythrophagocytosis in Gaucher cells. Arch Pathol Lab Med. 2004;128(10):1191-1192.
43. Bratosin D, Tissier J-P, Lapillonne H, et al. A cytometric study of the red blood cells in Gaucher disease reveals their abnormal shape that may be involved in increased erythrophagocytosis. Cytometry B Clin Cytom. 2011;80(1):28-37.
44. Franco M, Collec E, Connes P, et al. Abnormal properties of red blood cells sug- gest a role in the pathophysiology of Gaucher disease. Blood. 2013; 121(3):546- 555.
596
haematologica | 2018; 103(4)